FDA Approved: KEPIVANCE — Supplemental Application (Swedish Orphan Biovitrum AB (publ))

View source ↗

Summary

FDA approved a supplemental application for Kepivance (palifermin) to update the labeling related to mucositis prevention in patients with hematologic malignanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Kepivance (Palifermin)

Snippet

SUPPL AP for KEPIVANCE (PALIFERMIN)